SCHEMBL14980792

SCHEMBL14980792

Cc1cc(O)ccc1N(C)C(=O)CN(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 9/20 0.39
▸ HSD17B2 P37059 7/20 0.39
▸ CA12 O43570 2/20 0.36
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ CA7 P43166 2/20 0.36
▸ CA9 Q16790 2/20 0.36
▸ CA14 Q9ULX7 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ RGS12 O14924 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2205243 0.80 LMNA (0.48) HSD17B1HSD17B2SMN1; SMN2CYP3A4KMT2A
SCHEMBL9131390 0.78 HSD17B1 (0.36) HSD17B1HSD17B2CA12CA1CA2
SCHEMBL6561636 0.72 ESR1 (0.47) TDP1CYP3A4KMT2AHTTMEN1
SCHEMBL9056396 0.69 ESR1 (0.40) HSD17B1HSD17B2SMN1; SMN2TDP1CYP3A4
SCHEMBL2206662 0.68 IGF1R (0.40) CYP3A4KMT2AHTTMEN1ALDH1A1
SCHEMBL22887375 0.68 CA12 (0.49) HSD17B1HSD17B2CA12CA1CA2
SCHEMBL1891685 0.68 HSD17B1 (0.45) HSD17B1HSD17B2SMN1; SMN2KMT2ANPC1
SCHEMBL23142841 0.67 ALDH1A1 (0.35) HSD17B1HSD17B2CYP3A4KMT2AMEN1
SCHEMBL20170484 0.67 HSD17B3 (0.42) HSD17B1HSD17B2CA12CA1CA2
SCHEMBL18509438 0.67 ESR2 (0.36) HSD17B1HSD17B2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188292-B1 2- [ (2-{PHENYLAMINO}-1H-PYRROLO [2, 3-D]PYRIMIDIN-4-YL) AMINO]BENZAMIDE DERIVATIVES AS IGF-1R INHIBITORS FOR THE TREATMENT OF CANCER GLAXOSMITHKLINE IP DEV LTD (GB) 2013-05-29 — — EP disclosed
Send feedback